常规放射治疗与89Sr核素治疗对骨转移性疼痛的临床效果对比  

Comparison of the effects of conventional radiotherapy and 89Sr nuclides on patients with bone metastatic pain

作　　者：张丽莉 Zhang Lili(Department of Nuclear Medicine, Hebi People’s Hospital, Hebi 458030, China)

机构地区：[1]河南省鹤壁市人民医院核医学科,458030

出　　处：《中国实用医刊》2019年第12期73-75,共3页Chinese Journal of Practical Medicine

摘　　要：目的对比骨转移性疼痛患者应用常规放射及89Sr核素治疗后的效果。方法用掷币法将2016年10月至2017年10月鹤壁市人民医院核医学科85例骨转移疼痛患者分为两组,常规组42例行常规剂量分割放疗治疗,核素组43例予89Sr核素治疗,对比两组疼痛状况及疗效。结果核素组疼痛治疗后有效缓解时间短于常规组(P<0.05),核素组VAS评分及总有效率与常规组比较,差异未见统计学意义(P>0.05)。结论骨转移疼痛患者经常规放疗或核素治疗疼痛缓解效果相当,后者疼痛缓解较常规放疗快,临床应根据患者情况进行治疗。Objective To compare the effects of conventional radiotherapy and 89Sr nuclides after treatment of patients with bone metastatic pain. Methods Eighty-five patients with bone metastasis pain in Nuclear Medicine Department of Hebi People’s Hospital from October 2016 to Octorer 2017 were divided into two groups by coin toss method, 42 patients in the conventional group received conventional dose-fractionated radiotherapy, and 43 patients in the radionuclide group were treated with 89Sr nuclides. The pain and efficacy between the two groups were compared. Results The effective remission time after pain treatment in the radionuclide group was shorter than that in the conventional group (P<0.05). The visual conalogue scale score and total effective rate of nuclide group were compared with those of routine group, there was no significant difference (P>0.05). Conclusions Patients with bone metastases have similar pain relief effects by conventional radiotherapy or radionuclide therapy, but their pain relief is shorter than conventional radiotherapy, and clinical treatment should be based on the patient’s condition.

关 键 词：常规放射治疗 骨转移性疼痛 89Sr核素治疗 疼痛程度 

分 类 号：R730.55[医药卫生—肿瘤]